Literature DB >> 19820427

Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland.

Catherine Myers1, Klara M Posfay-Barbe, Christoph Aebi, Jean-Jacques Cheseaux, Christian Kind, Christoph Rudin, David Nadal, Claire-Anne Siegrist.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV)-infected children are at increased risk of infections caused by vaccine preventable pathogens, and specific immunization recommendations have been issued.
METHODS: A prospective national multicenter study assessed how these recommendations are followed in Switzerland and how immunization history correlates with vaccine immunity.
RESULTS: Among 87 HIV-infected children (mean age: 11.1 years) followed in the 5 Swiss university hospitals and 1 regional hospital, most (76%) had CD4 T cells >25%, were receiving highly active antiretroviral treatment (79%) and had undetectable viral load (60%). Immunization coverage was lower than in the general population and many lacked serum antibodies to vaccine-preventable pathogens, including measles (54%), varicella (39%), and hepatitis B (65%). The presence of vaccine antibodies correlated most significantly with having an up-to-date immunization history (P<0.05). An up-to-date immunization history was not related to age, immunologic stage, or viremia but to the referral medical center.
CONCLUSIONS: All pediatricians in charge of HIV-infected children are urged to identify missing immunizations in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19820427     DOI: 10.1097/INF.0b013e3181a78348

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland.

Authors:  Pierre Alex Crisinel; Klara Maria Posfay-Barbe; Christoph Aebi; Jean-Jacques Cheseaux; Christian Kahlert; Christoph Rudin; David Nadal; Claire-Anne Siegrist
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

3.  Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.

Authors:  Laura Sticchi; Bianca Bruzzone; Patrizia Caligiuri; Emanuela Rappazzo; Michele Lo Casto; Laura De Hoffer; Giulia Gustinetti; Claudio Viscoli; Antonio Di Biagio
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.

Authors:  Regina C M Succi; Margot R Krauss; D Robert Harris; Daisy M Machado; Maria Isabel de Moraes-Pinto; Marisa M Mussi-Pinhata; Noris Pavia Ruz; Russell B Pierre; Lenka Kolevic; Esau Joao; Irene Foradori; Rohan Hazra; George K Siberry
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

5.  Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Diederick E Grobbee; Shabir A Madhi
Journal:  EClinicalMedicine       Date:  2018-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.